US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on new policies to reduce the ability of brand drug makers to use REMS programs as a way to block timely generic drug entry, helping promote competition and access

FDA Commissioner on new policies to reduce ability of brand drug makers to use REMS programs to block timely generic drug entry
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on new policies to reduce the ability of brand drug makers to use REMS programs as a way to block timely generic drug entry, helping promote competition and access

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on the signing of the Right to Try Act

FDA stands ready to implement the Right to Try Act in a way that achieves Congress’ intent to promote access and protect patients
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on the signing of the Right to Try Act

US FDA News: FDA approves new treatment for moderately to severely active ulcerative colitis

FDA today expanded the approval of Xeljanz (tofacitinib) to include adults with moderately to severely active ulcerative colitis.
Read more: FDA approves new treatment for moderately to severely active ulcerative colitis

US FDA News: As part of efforts to combat opioid crisis, FDA launches innovation challenge to spur development of medical devices ‒ including digital health and diagnostics ‒ that target pain, addiction and diversion

As part of efforts to combat opioid crisis, FDA launches innovation challenge to spur development of medical devices ‒ including digital health and diagnostics ‒ that target pain, addiction and diversion
Read more: As part of efforts to combat opioid crisis, FDA launches innovation challenge to spur development of medical devices ‒ including digital health and diagnostics ‒ that target pain, addiction and diversion

Pharma Reviews: CPhI report predicts new finished product manufacturing hub in Middle East

A new report by CPhI forecasts sizable changes ahead for the pharma ... Manufacturers in India look very well placed to capitalise thanks to the recent ...
Read more: CPhI report predicts new finished product manufacturing hub in Middle East

Pharma Reviews: There is no great trigger for the market to move upwards: Pradip P Shah, IndAsia Fund Advisors

IT and pharma will benefit from not just the currency depreciation but because of their being able to service. For instance, Indian IT companies are ...
Read more: There is no great trigger for the market to move upwards: Pradip P Shah, IndAsia Fund Advisors

US FDA News: X-Jow and Acne Shave Products by Shadow Holdings: Voluntary Recall - Due to Possible Bacterial Contamination

The products may be contaminated with bacteria. Topical administration of the products could result in potentially serious bacterial infections in immunocompromised individuals.
Read more: X-Jow and Acne Shave Products by Shadow Holdings: Voluntary Recall - Due to Possible Bacterial Contamination

Pharma Reviews: KDPMA organises day-long event to deliberate on 'The Essential Journey from Schedule M to PICS'

The Pharmaceutical Inspection Co-operation Scheme (PICS) which is on the top of the mind for India is a course of action to harmonise inspection ...
Read more: KDPMA organises day-long event to deliberate on 'The Essential Journey from Schedule M to PICS'

Pharma Reviews: Experts highlight digital technology to transform pharma operations at PharmaNext 2018

Indian pharma industry is poised to play a key role in automating its plants and labs by treading the digital technology path, stated experts at the ...
Read more: Experts highlight digital technology to transform pharma operations at PharmaNext 2018

Pharma Jobs: Dean - Engineering

Company: ValeurHR E Solutions Pvt Ltd
Experience: 0 to 50
location: Solan
Ref: 22280902

Read more: Dean - Engineering

Pharma Jobs: Associate Projects

Company: ValeurHR E Solutions Pvt Ltd
Experience: 3 to 5
location: Pune
Ref: 22280932
Summary: Coding, Scripting and Automation testing

Read more: Associate Projects

Pharma Jobs: Associate Consultant-SBC

Company: ValeurHR E Solutions Pvt Ltd
Experience: 3 to 4
location: Anywhere
Ref: 22281198
Summary: Knowledge: • Familiarity with Packet core, IN, Policy, VAS platforms Technologies, Protocols & Standards, DNS,NAT• Understanding of Openstack and VMware Cloud • Knowledge of SIP, VoIP/IMS/VoLTE and ATCA/C7000 HW platforms.....
Read more: Associate Consultant-SBC

Pharma Jobs: Intellimatch

Company: ValeurHR E Solutions Pvt Ltd
Experience: 2 to 5
location: Delhi Region, Delhi
Ref: 22281220
Summary: Intellimatch developer

Read more: Intellimatch

Pharma Jobs: Engineering Manager

Company: ValeurHR E Solutions Pvt Ltd
Experience: 0 to 50
location: Bengaluru / Bangalore
Ref: 22281249
Summary: Coding , Design , Architecture , Communication , Org Development, people management

Read more: Engineering Manager

Pharma Jobs: Aptitude Trainer

Company: ValeurHR E Solutions Pvt Ltd
Experience: 1 to 3
location: Solan
Ref: 22281272
Summary: • Responsible for Training the Students on Quantitative Aptitude for various tests. • Content generation for the training. • Delivery of Training • Setting up measurement metrics for measuring the performance of the trainees.....
Read more: Aptitude Trainer

Pharma Jobs: Associate Consultant-SBC

Company: ValeurHR E Solutions Pvt Ltd
Experience: 0 to 50
location: Anywhere
Ref: 22281275
Summary: Knowledge: • Familiarity with Packet core, IN, Policy, VAS platforms Technologies, Protocols & Standards, DNS,NAT• Understanding of Openstack and VMware Cloud • Knowledge of SIP, VoIP/IMS/VoLTE and ATCA/C7000 HW platforms.....
Read more: Associate Consultant-SBC

US FDA News: 95% Ethyl Alcohol Product by Ethanol Extraction: Recall - Due to a Possible Contamination with Methanol

Methanol,a highly toxic type of alcohol, can cause serious and sometimes fatal damage if ingested by humans or animals.
Read more: 95% Ethyl Alcohol Product by Ethanol Extraction: Recall - Due to a Possible Contamination with Methanol

US FDA News: Oral Over-the-Counter Benzocaine Products: Drug Safety Communication - Risk of Serious and Potentially Fatal Blood Disorder

Oral over-the-counter benzocaine products should not be used to treat infants and children younger than 2 years and should only be used in adults and children 2 years and older if they contain certain warnings on the drug label.
Read more: Oral Over-the-Counter Benzocaine Products: Drug Safety Communication - Risk of Serious and Potentially Fatal Blood Disorder

Pharma Reviews: The 'India Pharma Week' Moves to Delhi-NCR in 2018

India contributes the second largest share of pharmaceutical and biotech workforce in the world. In February 2018, the Indian pharmaceutical market ...
Read more: The 'India Pharma Week' Moves to Delhi-NCR in 2018

US FDA News: FDA takes action against the use of OTC benzocaine teething products due to serious safety risk, lack of benefit

OTC oral health products containing benzocaine for the temporary relief of sore gums due to teething in infants or children should no longer be marketed. FDA is asking companies to stop selling these products for such use and requesting that companies add new warnings to all other benzocaine oral health products to describe certain serious risks.
Read more: FDA takes action against the use of OTC benzocaine teething products due to serious safety risk, lack of benefit

Pharma Reviews: The 'India Pharma Week' Moves to Delhi-NCR in 2018

Indian pharmaceutical sector accounts for about 3.1 - 3.6 per cent of the global pharmaceutical industry in value terms and 10 per cent in volume terms ...
Read more: The 'India Pharma Week' Moves to Delhi-NCR in 2018

Pharma Reviews: Marketers to be liable for violation of rules by pharma companies

Companies marketing medicines in India will soon be as liable as the manufacturers for any violations of drug regulations that could lead to spurious ...
Read more: Marketers to be liable for violation of rules by pharma companies

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on new FDA actions to keep consumers safe from the harmful effects of sun exposure, and ensure the long-term safety and benefits of sunscreens

The FDA is announcing three new efforts as part of a comprehensive set of actions to advance the FDA’s framework for sun protection products ahead of this coming summer
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on new FDA actions to keep consumers safe from the harmful effects of sun exposure, and ensure the long-term safety and benefits of sunscreens

US FDA News: HeartMate 3™ Left Ventricular Assist System: Class I Recall - Due to Potential Malfunction that may Lead to Graft Occlusion

The class I recall is due to a malfunction in the device’s outflow graft assembly that may cause the outflow graft to twist and close up (occlusion) over time. Occlusion of the outflow graft can reduce or stop pump flow and set off a persistent low flow alarm in the system. A reduction in pump can lead to serious adverse events such as blood clots and death.
Read more: HeartMate 3™ Left Ventricular Assist System: Class I Recall - Due to Potential Malfunction that may Lead to Graft Occlusion

US FDA News: FDA warns companies selling illegal, unapproved kratom products marketed for opioid cessation, pain treatment and other medical uses

FDA warns companies selling illegal, unapproved kratom products marketed for opioid cessation, pain treatment and other medical uses
Read more: FDA warns companies selling illegal, unapproved kratom products marketed for opioid cessation, pain treatment and other medical uses

Pharma Reviews: UBM India Announces the Much Awaited CPhI's 7th Annual Pharma Confex in Mumbai

CPhI Conferences, a division of UBM India, which hosts a number of successful pharmaceutical conferences, has announced its premier event, 'The ...
Read more: UBM India Announces the Much Awaited CPhI's 7th Annual Pharma Confex in Mumbai

US FDA News: FDA approves new drug for patients with chronic liver disease who have low blood platelets and are undergoing a medical procedure

FDA approves Doptelet (avatrombopag) to treat thrombocytopenia in adults with chronic liver disease who are scheduled to undergo a medical procedure.
Read more: FDA approves new drug for patients with chronic liver disease who have low blood platelets and are undergoing a medical procedure

US FDA News: Homeopathic Teething Drops, Nausea Drops, Intestinal Colic Drops, Stomach Calm, Expectorant Cough Syrup, Silver-Zinc Throat Spray, and Argentum Elixir by MBI Distributing: Recall - Due to a Lack of Adequate Controls

Manufacturing products without proper process controls increases the probability that products will vary in strength, quality and purity
Read more: Homeopathic Teething Drops, Nausea Drops, Intestinal Colic Drops, Stomach Calm, Expectorant Cough Syrup, Silver-Zinc Throat Spray, and Argentum Elixir by MBI Distributing: Recall - Due to a Lack of Adequate Controls

Pharma Reviews: Rising crude: Consumers brace for price impact across categories

Ajay Seth, Head Channel Operations, Panasonic India said that the ... High crude oil prices may not be good news for pharmaceutical industry.
Read more: Rising crude: Consumers brace for price impact across categories

Pharma Reviews: CPhI's 7th Annual Innopack Pharma Confex to be held in Mumbai from May 24 – 25

Pierre Pienaar, President, World Packaging Organisation; Daara Patel, Secretary-General, Indian Drug Manufacturers Association; Ashok Kumar ...
Read more: CPhI's 7th Annual Innopack Pharma Confex to be held in Mumbai from May 24 – 25

US FDA News: Keytruda (pembrolizumab) or Tecentriq (atezolizumab): FDA Alerts Health Care Professionals and Investigators: FDA Statement - Decreased Survival in Some Patients in Clinical Trials Associated with Monotherapy

Early reviews found patients in the monotherapy arms of both trials with PD-L1 low status had decreased survival compared to patients who received cisplatin- or carboplatin-based chemotherapy.
Read more: Keytruda (pembrolizumab) or Tecentriq (atezolizumab): FDA Alerts Health Care Professionals and Investigators: FDA Statement - Decreased Survival in Some Patients in Clinical Trials Associated with Monotherapy

US FDA News: 7K and Poseidon 4500 by Shoreside Enterprises: Voluntary Recall - Due to Presence of Undeclared Sildenafil and/or Tadalafil

Use of products with the undeclared active ingredients, sildenafil and tadalafil, may pose a threat to consumers because the active ingredient may interact with nitrates found in some prescription drugs (such as nitroglycerin) and may cause a significant drop in blood pressure that may be life threatening. Among the adult male population who are most likely to use these products, adult males who use nitrates for cardiac conditions are the most at risk from these products. These products are considered tainted. To date, Shoreside Enterprises, Inc. has not received any reports of adverse events related to this recall.
Read more: 7K and Poseidon 4500 by Shoreside Enterprises: Voluntary Recall - Due to Presence of Undeclared Sildenafil and/or Tadalafil

US FDA News: Juluca, Tivicay, Triumeq (dolutegravir): FDA to Evaluate - Potential Risk of Neural Tube Birth Defects

Preliminary results from an ongoing observational study in Botswana found that women who received dolutegravir at the time of becoming pregnant or early in the first trimester appear to be at higher risk for these defects. Neural tube defects are birth defects that can occur early in pregnancy when the spinal cord, brain, and related structures do not form properly. To date, in this observational study there are no reported cases of babies born with neural tube defects to women starting dolutegravir later in pregnancy. We are investigating this new safety issue and will update the public when we have more information.
Read more: Juluca, Tivicay, Triumeq (dolutegravir): FDA to Evaluate - Potential Risk of Neural Tube Birth Defects

US FDA News: MindFrame Capture LP Revascularization Device by Medtronic: Class I Recall - Due to Wire Material That May Break or Separate During Use

There is a risk of the delivery wire breaking or separating during use. The clot retriever could be left inside the patient's bloodstream, and this or the attempts made to retrieve the device, can lead to further complications including bleeding, additional blockage of blood vessels, more severe stroke symptoms, or death.
Read more: MindFrame Capture LP Revascularization Device by Medtronic: Class I Recall - Due to Wire Material That May Break or Separate During Use

US FDA News: FDA approves novel preventive treatment for migraine

FDA approves Aimovig for the preventive treatment of migraine. Aimovig works by blocking the activity of a molecule that is involved in migraine attacks.
Read more: FDA approves novel preventive treatment for migraine

Pharma Reviews: Industry body asks govt to strike balance between quality and cost while framing 'Ayushman Bharat ...

Even as the government is working on its new 'Ayushman Bharat' health insurance policy, Medical Technology Association of India (MTaI), the lobby ...
Read more: Industry body asks govt to strike balance between quality and cost while framing 'Ayushman Bharat ...

US FDA News: FDA requires additional e-cigarette makers to provide critical information so the agency can better examine youth use and product appeal, amid continued concerns around youth access to products

FDA continued to take important steps to address youth use of e-cigarettes by sending official requests for information to four e-cigarette makers requiring them to submit important documents to better understand the youth appeal.
Read more: FDA requires additional e-cigarette makers to provide critical information so the agency can better examine youth use and product appeal, amid continued concerns around youth access to products

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on new agency efforts to shine light on situations where drug makers may be pursuing gaming tactics to delay generic competition

FDA statement on certain tactics drug makers may be pursuing to delay generic competition
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on new agency efforts to shine light on situations where drug makers may be pursuing gaming tactics to delay generic competition

Pharma Reviews: Whistle blowing in Indian Banking

They also feel that the recent surfacing of the frauds in Indian Banking ... In this case a senior executive of an Indian pharma company after blowing the ...
Read more: Whistle blowing in Indian Banking

US FDA News: FDA approves first epoetin alfa biosimilar for the treatment of anemia

FDA approves Retacrit (epoetin alfa-epbx) as a biosimilar to Epogen/Procrit (epoetin alfa) for the treatment of anemia
Read more: FDA approves first epoetin alfa biosimilar for the treatment of anemia

Pharma Reviews: Commerce Ministry in talks with Chinese FDA for speedy approval of Indian pharma products

Indian pharma companies may look forward to speedy product registrations with the Chinese Food and Drug Administration (CFDA).
Read more: Commerce Ministry in talks with Chinese FDA for speedy approval of Indian pharma products

Pharma Jobs: Job opening for Medical coding- Chennai

Company: Skyline Medical Coding LLP
Experience: 0 to 4
location: Chennai
Ref: 22232503
Summary: Medical Coders should review the documentation contained in patients medical records and translate it into universally accepted industry-standard medical code by using ICD 10-CM, CPT & HCPCS EDUCATION : B.Sc Or M.Sc (....
Read more: Job opening for Medical coding- Chennai

Pharma Jobs: Biotechnology Walk In Interview

Company: Confidential
Experience: 0 to 5
location: Pune
Ref: 22232703
Summary: Greenland Automation An ISO 9001:2008 Certified Company Company Name -Greenland Automation India HR snehal Phone: 7249866047 7249866387 https://ift.tt/2rGAHYm Note-Upload Resume On Website.

Read more: Biotechnology Walk In Interview

Pharma Jobs: Microbiologist Walk In Interview

Company: Confidential
Experience: 0 to 5
location: Pune
Ref: 22232728
Summary: Greenland Automation An ISO 9001:2008 Certified Company Company Name -Greenland Automation India HR snehal Phone: 7249866047 7249866387 https://ift.tt/2rGAHYm Note-Upload Resume On Website.

Read more: Microbiologist Walk In Interview

Pharma Reviews: To counter China, Made-in-India drugs could soon be made in Uzbekistan

The deal is clear as India is one of the largest manufacturers of drugs across the globe,” a senior official from the Department of Pharmaceuticals said, ...
Read more: To counter China, Made-in-India drugs could soon be made in Uzbekistan

Pharma Reviews: Ghana calls for bigger Indian role to boost industry

Gold comprises a majority of Ghana's total export to India. Ghana is also creating a few industrial parks of which one being the pharma park to promote ...
Read more: Ghana calls for bigger Indian role to boost industry

Pharma Reviews: Local medical devices industry wants Modi to encourage indigenous manufacturing

"India needs to encourage indigenous manufacturing of medical devices to reduce dependency and withstand monopolistic threats by US industry ...
Read more: Local medical devices industry wants Modi to encourage indigenous manufacturing

Pharma Reviews: Trump's drug proposals mean status quo for Indian cos, but may have implication for India-US ...

But the blueprint did not call for Medicare to negotiate lower prescription drug prices, an idea the Indian industry had feared all along. Medicare is a ...
Read more: Trump's drug proposals mean status quo for Indian cos, but may have implication for India-US ...

Pharma Reviews: Trump drug proposals status quo for Indian cos, but may have implication for India-US trade relations

US is an important market for Indian drug makers constituting about 40.6 ... prescription drug prices, an idea the Indian industry had feared all along.
Read more: Trump drug proposals status quo for Indian cos, but may have implication for India-US trade relations

Pharma Reviews: Indian pharma firms lukewarm on China's lowered drug tariffs considering lengthy approvals

The announcement was made to provide opening to Indian pharmaceutical firms to market their economically priced drugs. Beijing: China's ...
Read more: Indian pharma firms lukewarm on China's lowered drug tariffs considering lengthy approvals

Pharma Reviews: China's plans to import Indian drugs fail to enthuse Indian pharma firms

China is the second largest market for pharmaceuticals after the US. Image for representational purpose only. - Reuters ...
Read more: China's plans to import Indian drugs fail to enthuse Indian pharma firms

Pharma Reviews: PTI Exclusive: Chinas plans to import Indian drugs fail to enthuse Indian pharmaceutical firms

Beijing, May 13 (PTI) Chinas much-publicised announcement to slash tariffs on 28 medicines, including cancer drugs from India, has failed to create ...
Read more: PTI Exclusive: Chinas plans to import Indian drugs fail to enthuse Indian pharmaceutical firms

Pharma Reviews: China's plans to import Indian drugs fail to enthuse Indian pharmaceutical firms

China's much-publicised announcement to slash tariffs on 28 medicines, including cancer drugs from India, has failed to create any buzz among the ...
Read more: China's plans to import Indian drugs fail to enthuse Indian pharmaceutical firms

Pharma Reviews: PTI Exclusive: China's plans to import Indian drugs fail to enthuse Indian pharmaceutical firms

Good news for India's pharmaceutical industry and medicine export to China. I believe this will help reduce trade imbalance between China and India ...
Read more: PTI Exclusive: China's plans to import Indian drugs fail to enthuse Indian pharmaceutical firms

Pharma Reviews: Indian pharma firms bear brunt of US President Trump drug stance

On Friday, pharma shares slumped by up to six per cent, with Sun Pharmaceutical slipping six per cent to Rs 468 on BSE during afternoon trade, ...
Read more: Indian pharma firms bear brunt of US President Trump drug stance

US FDA News: Vyaire Medical AirLife Resuscitation Device & Broselow Convenience Kit by Vyaire Medical: Class I Recall - Due to Risk of Malfunction Caused by Error in Product Design

Vyaire Medical is recalling the AirLife Resuscitation Device & Broselow Convenience Kit due to an error in its product design that may result in difficultly or the inability to disconnect the mask from the elbow of the resuscitator.
Read more: Vyaire Medical AirLife Resuscitation Device & Broselow Convenience Kit by Vyaire Medical: Class I Recall - Due to Risk of Malfunction Caused by Error in Product Design

US FDA News: FDA expands approval of Gilenya to treat multiple sclerosis in pediatric patients

FDA approves Gilenya (fingolimod) to treat multiple sclerosis MS in children age 10 and older. This is the first FDA approval of a drug to treat MS in pediatric patients
Read more: FDA expands approval of Gilenya to treat multiple sclerosis in pediatric patients

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on the Trump Administration’s plan to lower drug prices

Statement from FDA Commissioner Scott Gottlieb, M.D., on the Trump Administration’s plan to lower drug prices
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on the Trump Administration’s plan to lower drug prices

Pharma Reviews: Capping Drug Prices Is Not the Answer to High Pvt Healthcare Costs

The public healthcare system in India is, to say the least, a disaster. ... All attempts by the National Pharmaceutical Pricing Authority (NPPA), the ...
Read more: Capping Drug Prices Is Not the Answer to High Pvt Healthcare Costs

Pharma Reviews: Affordable solutions needed to intensify innovations in Indian pharma sector: DGHS

Advanced, affordable and accessible solutions is the only way forward towards intensifying the innovations in Indian pharma sector, a top Union ...
Read more: Affordable solutions needed to intensify innovations in Indian pharma sector: DGHS

Pharma Reviews: Indian Intellectual Property and liabilities law creates obstacle to invest in pharma sector

IP sector regulations and liabilities law has been not just a hindrance but a barrier and impediment (for the US pharma companies to invest in India).
Read more: Indian Intellectual Property and liabilities law creates obstacle to invest in pharma sector

US FDA News: Medline Remedy Essentials No-Rinse Cleansing Foam: Avoid Using - Multistate Outbreak of Burkholderia Cepacia Complex

CDC reports that there are 10 confirmed cases of infection caused by bacteria within the Burkholderia cepacia complex, also commonly called B. cepacia, in three states: California (2), Pennsylvania (7), and New Jersey (1). These patients were already hospitalized for acute conditions and acquired the infections while hospitalized. The infections have been linked to the Medline product, Remedy Essentials No-Rinse Cleansing Foam.
Read more: Medline Remedy Essentials No-Rinse Cleansing Foam: Avoid Using - Multistate Outbreak of Burkholderia Cepacia Complex

Pharma Reviews: ASSOCHAM urges greater utilisation of technology in pharmaceuticals

Advanced, affordable and accessible solutions are the only way forward towards intensifying the innovations in the Indian pharmaceutical sector, a top ...
Read more: ASSOCHAM urges greater utilisation of technology in pharmaceuticals

Pharma Reviews: 'Indian IP and liabilities law barrier to pharma R&D investment'

BOSTON: India's intellectual property regulations and liabilities laws pose a major barrier to foreign companies, specially from the US, that prevents ...
Read more: 'Indian IP and liabilities law barrier to pharma R&D investment'

US FDA News: FDA warns more companies to stop misleading kids with e-liquids that resemble kid-friendly foods as part of Youth Tobacco Prevention Plan

FDA warns more companies to stop misleading kids with e-liquids that resemble kid-friendly foods as part of Youth Tobacco Prevention Plan
Read more: FDA warns more companies to stop misleading kids with e-liquids that resemble kid-friendly foods as part of Youth Tobacco Prevention Plan

US FDA News: Fabius Anesthesia Machines by Dräger Medical: Class I Recalls - Due to Production Step Error

Dräger Medical is recalling the Fabius Anesthesia machines due to excessive oil that was not removed at the time of production. Such excess oil may interfere with the position detector of the ventilation motor during operation and may cause ventilation to fail. A halt in ventilation may lead to serious adverse health consequences, including patient injury or death.
Read more: Fabius Anesthesia Machines by Dräger Medical: Class I Recalls - Due to Production Step Error

Pharma Reviews: Affordable solutions needed to intensify innovations in Indian pharma sector: DGHS

She also urged the Indian pharmaceutical industry to take advantage of opportunities that have come up owing to recent revolutions at molecular level ...
Read more: Affordable solutions needed to intensify innovations in Indian pharma sector: DGHS

Pharma Reviews: Affordable solutions needed to intensify innovations in Indian pharma sector: DGHS

She also urged the Indian pharmaceutical industry to take advantage of opportunities that have come up owing to recent revolutions at molecular level, genomics, proteomics, metabolomics, bioinformatics and imaging technology which had led to advanced research in terms of understanding the ...
Read more: Affordable solutions needed to intensify innovations in Indian pharma sector: DGHS

Pharma Reviews: Prabhu urges pharma exporters to expand to new markets

Ministry of Commerce and Industry Suresh Prabhu on Tuesday urged the Indian pharmaceutical companies to look for new markets, adding that the government is committed to get access to the sector in key global markets. After inaugurating the 6th annual International Exhibition of Pharma and ...
Read more: Prabhu urges pharma exporters to expand to new markets

Pharma Reviews: Prabhu urges pharma firms to do more R&D, develop new markets

New Delhi, Indian pharmaceutical companies need to increase R&D investments and develop new markets in order to boost their exports, Commerce Minister Suresh Prabhu said on Tuesday. ... Regions like Latin America and Africa hold huge potential for export of Indian pharma products, Prabhu said.
Read more: Prabhu urges pharma firms to do more R&D, develop new markets

Pharma Reviews: Invest more in R&D: Suresh Prabhu to pharma firms

Commerce and Industry Minister Suresh Prabhu has asked pharma ... export potential for Indian pharmaceutical products and more investments on ...
Read more: Invest more in R&D: Suresh Prabhu to pharma firms

US FDA News: Neurovascular Stents Used for Stent-Assisted Coiling (SAC): Letter to Health Care Providers - Recommendations Associated With the Use of These Devices in the Treatment of Unruptured Brain Aneurysms

The FDA has received reports associated with the use of these devices in the treatment of unruptured brain aneurysms that suggest some events of peri-procedural stroke and/or death may have been related to procedural risks or patient selection related factors. These factors include patients who had serious co-morbidities resulting in a reduced life expectancy, or who were intolerant to required anticoagulation or anti-platelet therapy.
Read more: Neurovascular Stents Used for Stent-Assisted Coiling (SAC): Letter to Health Care Providers - Recommendations Associated With the Use of These Devices in the Treatment of Unruptured Brain Aneurysms

Pharma Reviews: CDSCO increases WHO GMP certificate to three years for ease of doing business

The size of the Indian pharmaceutical industry is expected to increase to $50 billion in the next few years from the present size of $32-33 billion, ...
Read more: CDSCO increases WHO GMP certificate to three years for ease of doing business

Pharma Reviews: Prabhu urges pharma firms to do more R&D, develop new markets

Indian pharmaceutical companies need to increase R&D investments and develop new markets in order to boost their exports, Commerce Minister ...
Read more: Prabhu urges pharma firms to do more R&D, develop new markets

Pharma Reviews: We are committed to get Access to Indian Pharma in Global Market – Prabhu

New Delhi-We are fully committed to promoting the Indian pharmaceuticals industry globally, said Commerce and Industry Minister, Mr Suresh Prabhu, ...
Read more: We are committed to get Access to Indian Pharma in Global Market – Prabhu

US FDA News: Piperacillin and Tazobactam for Injection, USP 3.375 g Vials by AuroMedics Pharma: Recall - Vials Contain Particulate Matter

Piperacillin and Tazobactam for Injection, USP 3.375 g by AuroMedics Pharma: Recall: Exposure to particulate matter may result in local irritation/swelling or more serious outcomes.
Read more: Piperacillin and Tazobactam for Injection, USP 3.375 g Vials by AuroMedics Pharma: Recall - Vials Contain Particulate Matter

US FDA News: Ampicillin and Sulbactam for Injection USP, 3 g Single-Dose Vials by AuroMedics Pharma: Recall - Presence of Red Particulate Matter

Ampicillin and Sulbactam for Injection USP, 3 g/Single-Dose Vials by AuroMedics Pharma: Recall - Exposure to particulate may result in local site reaction, thromboembolic events and systemic immune response.
Read more: Ampicillin and Sulbactam for Injection USP, 3 g Single-Dose Vials by AuroMedics Pharma: Recall - Presence of Red Particulate Matter

Pharma Reviews: Centre to push pharma exports to China

He said that with a view to enabling the Indian pharmaceutical industry reach new markets, the Indian government has taken up the issue of market ...
Read more: Centre to push pharma exports to China

Pharma Reviews: Move afoot to push pharma exports in untapped markets: Prabhu

He said China has agreed for a high level bilateral Round Table to pave the way for Indian Pharma to get market access and penetration in their vast ...
Read more: Move afoot to push pharma exports in untapped markets: Prabhu

Pharma Reviews: Suresh Prabhu inaugurates International Exhibition of Pharma and Healthcare

... the Indian pharmaceuticals industry globally, said Commerce and Industry ... Shri Prabhu assured the global pharmaceutical players and regulators, ...
Read more: Suresh Prabhu inaugurates International Exhibition of Pharma and Healthcare

Pharma Reviews: Will Europe's New Data Protection Regulations Impact Indian Tech Sector? Here's What We Must ...

This is a question many Indian startups and enterprises are grappling with as ... companies who operate outside EU, most pharma and financial companies ... The report cites that Indian tech companies who are data collectors and ...
Read more: Will Europe's New Data Protection Regulations Impact Indian Tech Sector? Here's What We Must ...

Pharma Reviews: Invest more in R&D, develop new markets to boost pharma exports: Prabhu to industry

Regions like Latin America and Africa hold huge export potential for Indian pharmaceutical products, Prabhu said here while inaugurating the international exhibition of pharma and healthcare (iPHEX) here. "Make more investments in R&D activities so that the pipeline (for new medicines) do not get dry ...
Read more: Invest more in R&D, develop new markets to boost pharma exports: Prabhu to industry

US FDA News: Declaración del Dr. Scott Gottlieb, MD, comisionado de la FDA, sobre los beneficios de la aprobación del etiquetado en los menús para la salud pública

beneficios de la aprobación del etiquetado en los menús para la salud pública
Read more: Declaración del Dr. Scott Gottlieb, MD, comisionado de la FDA, sobre los beneficios de la aprobación del etiquetado en los menús para la salud pública

Pharma Reviews: 140 Indian firms invested $4bn in South Africa: CII-PwC

"In the healthcare sector, the entry of Indian pharma companies Ranbaxy and Cipla brought in drastic reduction in the cost of anti-retroviral drugs in ...
Read more: 140 Indian firms invested $4bn in South Africa: CII-PwC

US FDA News: FDA permits marketing of new endoscopic device for treating gastrointestinal bleeding

FDA permits marketing of new endoscopic device for treating gastrointestinal bleeding
Read more: FDA permits marketing of new endoscopic device for treating gastrointestinal bleeding

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on the public health benefits from enactment of menu labeling

Statement from FDA Commissioner Scott Gottlieb, M.D., on the public health benefits from enactment of menu labeling
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on the public health benefits from enactment of menu labeling

Pharma Reviews: Pharma exports can cross $20 bn by 2020: Chief of Pharmexcil

“If the governments are moving in that direction… they need to purchase generics from India,” he told ET in the run-up to the International Exhibition of Pharma and Healthcare in New Delhi this week. “The entire world is looking for alternative manufacturers of APIs as well as formulations.” This would be ...
Read more: Pharma exports can cross $20 bn by 2020: Chief of Pharmexcil

Pharma Reviews: India Inc invests over $4 billion in South Africa

Exports from India to South Africa include vehicle parts, transport equipment, drugs and pharmaceuticals, engineering goods, footwear, chemicals, textiles ... It further claimed that in the healthcare sector, the entry of Indian pharma companies Ranbaxy and Cipla brought in drastic reduction in the cost of ...
Read more: India Inc invests over $4 billion in South Africa

Pharma Reviews: Indian companies create 18000 jobs, invest USD 4 billion in South Africa; details here

It further claimed that in the healthcare sector, the entry of Indian pharma companies Ranbaxy and Cipla brought in drastic reduction in the cost of anti-retroviral drugs (ARVs) in South Africa, saving thousands of lives. “As this report outlines, Indian companies are demonstrating their commitment to ...
Read more: Indian companies create 18000 jobs, invest USD 4 billion in South Africa; details here

Pharma Reviews: 140 Indian firms invested $4bn in South Africa: CII-PwC

"In the healthcare sector, the entry of Indian pharma companies Ranbaxy and Cipla brought in drastic reduction in the cost of anti-retroviral drugs in South Africa, saving thousands of lives. Indian companies are taking steps to transfer skills to South Africans, particularly in the IT sector," it said.
Read more: 140 Indian firms invested $4bn in South Africa: CII-PwC

Pharma Reviews: 'Smart turnaround' in exports: Pharmexcil

The U.S. and rest of North America is the key market for Indian pharmaceutical industry, accounting for over 31% of the total exports. Stating this ...
Read more: 'Smart turnaround' in exports: Pharmexcil

Pharma Reviews: India's pharma exports cross $17 billion

Hyderabad: India's pharmaceutical exports have shown a smart turnaround in the last few months, with Europe and other key markets gaining traction and making up for slowdown in North America, an issue that would be brain-stormed at the forthcoming 'iPHEX' annual event of the apex industry body ...
Read more: India's pharma exports cross $17 billion

Pharma Reviews: India Emerges As Top Five Pharmaceuticals Markets Of The World

India's pharmaceutical industry has grown by leaps and bounds in the last three decades. As a result, it has emerged as world's third largest producer of drugs in terms of volume. The industry has posted double-digit growth over the last few years, rising to US $36.7 Billion in 2017 and projected to grow ...
Read more: India Emerges As Top Five Pharmaceuticals Markets Of The World

Pharma Reviews: Pharma exports top US$ 17 billion

India's pharmaceuticals exports have shown a smart turnaround in the last few months, with Europe and other key markets gaining an impressive traction and making up for slowdown in North America, an issue that would be brain-stormed at the forthcoming 'iPHEX' annual event of the apex industry ...
Read more: Pharma exports top US$ 17 billion

Pharma Reviews: 'Smart turnaround' in exports: Pharmexcil

Union Commerce and Industry Minister Suresh Prabhu is scheduled to ... Elaborating on the 2017-18 pharmaceutical exports, Pharmexcil said after ... North America is the key market for Indian pharmaceutical industry, accounting for ...
Read more: 'Smart turnaround' in exports: Pharmexcil

Pharma Reviews: China exempting import tariffs on 28 drugs unlikely to boost India's pharma exports

Although higher competitiveness in manufacturing is the main reason ... However, D.G. Shah, secretary general at Indian Pharmaceutical Alliance, ...
Read more: China exempting import tariffs on 28 drugs unlikely to boost India's pharma exports

US FDA News: FDA approves new uses for two drugs administered together for the treatment of BRAF-positive anaplastic thyroid cancer

FDA approves Tafinlar (dabrafenib) and Mekinist (trametinib), administered together, for the treatment of anaplastic thyroid cancer
Read more: FDA approves new uses for two drugs administered together for the treatment of BRAF-positive anaplastic thyroid cancer

Pharma Reviews: Indian pharma tussle for value status

"On one side where the Indian pharma industry is growing due to its key factors such as low manufacturing cost, technical growth, skilled workforce and a diverse ecosystem to strengthen the sector, on another side the growing number of manufacturers with substandard medicines has spoiled the ...
Read more: Indian pharma tussle for value status

Pharma Reviews: India to benefit as China lifts import duties on 28 drugs: Chinese envoy

During an informal summit between Chinese President Xi Jingping and Indian Prime minister Narendra Modi last month, China had pledged to look into the sticky issue of greater market access to Indian farm products and to resolve any issue that hurts the prospect of Indian pharmaceutical exports to ...
Read more: India to benefit as China lifts import duties on 28 drugs: Chinese envoy

Pharma Reviews: Will China's tariff exemption lead to increase in India's pharma exports?

Being a global player in generic pharmaceutical manufacturing, India had reasons to believe that it has the ability to export low cost, high quality medicines to China. Luo Zhaohui seemed to suggest that one of the major hurdles before India to increase its share of medicine exports to China - high tariffs ...
Read more: Will China's tariff exemption lead to increase in India's pharma exports?

Pharma Reviews: This Move by China Spells Good News For Medicine Manufacturers of India!

Good news for India's pharmaceutical industry and medicine export to China. ... “In fact, Brazil and Chile encouraged the entry of Indian pharma companies into their countries to put pressure on MNCs and local drug-makers to increase the availability of generics and reduce the cost of medicines,” says ...
Read more: This Move by China Spells Good News For Medicine Manufacturers of India!

Pharma Reviews: China says pharma-tariffs' removal will profit India, but will it?

Days after PM Narendra Modi's visit, China has announced it is removing import duties on 28 medicines effective May 1, a move that officials say will boost India's access to the market. "This will help reduce trade imbalance between China and India," Chinese Ambassador to India Luo Zhaohui said; ...
Read more: China says pharma-tariffs' removal will profit India, but will it?

Pharma Reviews: Import tariff exemption on 28 drugs will help reduce trade gap with India: Chinese envoy

“China has exempted import tariffs for 28 drugs, including all cancer drugs, from May 1. Good news for India's pharmaceutical industry and medicine export to China. I believe this will help reduce trade imbalance between China and India in the future,” Ambassador Luo Zhaohui tweeted on Thursday.
Read more: Import tariff exemption on 28 drugs will help reduce trade gap with India: Chinese envoy

Pharma Reviews: Pharmexcil to revive exports to South Asia

“As many as two dozen pharma firms from Nepal would be participating at the 'IPHEX, 2018', the annual global event of the $33 billion pharma industry. About 10 firms from Sri Lanka and half a dozen from Bangladesh would also arrive and engage with Indian industry. About 300 exhibitors and 600 ...
Read more: Pharmexcil to revive exports to South Asia

Pharma Reviews: Indian Pharma's Big Leap

Nagpur-based Zim Laboratories is a non-descript drug company with turnover in excess of Rs 250 crore. In the past two decades, Zim has been silently working on developing innovative and differentiated pharmaceutical products or specialty generic complex drugs. Recently, it developed a new product ...
Read more: Indian Pharma's Big Leap

Pharma Reviews: Marks Emballage leaps into big league with a record double Gallus Labelmaster 440 deal, adds ...

Baddi-based Marks Emballage has become the first Indian packaging company to order two Gallus Labelmaster flexo presses at a time, rounding off the investment with a Pantec Rhino II and ... The company started in 2013 with a modest label production facility to cater to pharma businesses in Baddi.
Read more: Marks Emballage leaps into big league with a record double Gallus Labelmaster 440 deal, adds ...

Pharma Reviews: Why the US and pharmaceutical giants want a provision in India's patent law revoked

In January, the Delhi High Court took up a long-pending writ petition about how patentees, particularly pharmaceutical giants, have been ignoring Section 146 of the Patents Act, 1970. Under this section, details on patent working are to be filed in Form 27. The global pharmaceutical industry has banded ...
Read more: Why the US and pharmaceutical giants want a provision in India's patent law revoked

US FDA News: FDA, FTC take action against companies misleading kids with e-liquids that resemble children’s juice boxes, candies and cookies

FDA, FTC take action against companies misleading kids with e-liquids that resemble children’s juice boxes, candies and cookies
Read more: FDA, FTC take action against companies misleading kids with e-liquids that resemble children’s juice boxes, candies and cookies

Pharma Reviews: Buffett may be sitting on $135-bn cash, but is still unlikely to invest in India

Raamdeo Agrawal, co-founder and fund manager, Ashish Somaiya, MD &CEO, an d Gautam Sinha Roy, Senior VP- Fund Manager, Motilal Oswal AMC, discuss Warren Buffett, the Oracle of Omaha and whether he is going to change his policy of not investing in India with ET Now's Tanvir Gill before the ...
Read more: Buffett may be sitting on $135-bn cash, but is still unlikely to invest in India